Diagnostics News and Research

RSS

Myriad Genetics awarded a $14.2 million contract for AIDS and hepatitis research

Myriad Genetics has announced that it has been awarded a five-year, $14.2 million contract by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

10 Jul 2004

Dexrazoxane reduces heart damage caused by childhood leukemia treatment with doxorubicin (Adriamycin)

A potent chemotherapy that is highly effective in treating the most common form of childhood leukemia can significantly harm the heart, but findings from a multi-center study

9 Jul 2004

Emerging infectious diseases will continue to confront society in unpredictable ways as long as humans and microbes co-exist

Emerging infectious diseases, which have shaped the course of humanity and caused incalculable suffering and death, will continue to confront society in unpredictable ways as long as humans and microbes co-exist

9 Jul 2004

Gum disease vaccination aim of world-first research

Vaccinating people against gum disease will be the aim of world-first Melbourne research that today receives a $21.2 million boost from the Federal Government.

2 Jul 2004

Delphi expands medical footprint

Delphi Medical Systems Corporation, a subsidiary of Delphi Corporation, recently signed a licensing agreement with Switzerland-based medical device company Debiotech, S.A.

29 Jun 2004

Australian biomedical scientists tackle malaria with on-line malaria information resource

Endemic in 101 countries, malaria affects an estimated 200-300 million people per year resulting in over 2 million deaths the majority of these being children. The World Health Organisation have calculated that a child under 5 years of age dies from malaria every 30 seconds. In simplistic terms, three factors have been identified as major reasons for these fatalities.

29 Jun 2004

62 percent of frequent antihistamine users did not test positive for allergies

A new study in the current issue of Journal of Managed Care Pharmacy concludes that 62 percent of frequent antihistamine users did not test positive for allergies.

28 Jun 2004

New medical imaging equipment provides early detection of skin cancer

Could You Have Skin Cancer? Do you know if you have skin cancer or if you have skin lesions that could develop into skin cancer? Early detection of these ticking time bombs enhances survival.

From Siemens Healthineers 28 Jun 2004

Genetic variation that doubles the risk for rheumatoid arthritis

A team of researchers has discovered a genetic variation that doubles the risk for rheumatoid arthritis (RA).

24 Jun 2004

Biotech organization receives $1 million form Bill & Melinda Gates

The Biotechnology Industry Organization (BIO) today announced the launch of BIO Ventures for Global Health (BVGH), a new nonprofit organization that will work to enlist the biotechnology industry in the fight against neglected diseases. BVGH has received a $1 million start-up grant from the Bill & Melinda Gates Foundation.

17 Jun 2004

New Cincinnati adult diabetes center

The Diabetes Center at the University of Cincinnati is a joint effort by UC and community leaders to improve diabetes care in the region and open the door to more community programs addressing the health care needs of people with diabetes.

15 Jun 2004

New software helps understanding of protein-protein docking

These algorithms enable more efficient life science research by helping scientists to understand the action of therapeutically interesting proteins by predicting the manner in which two proteins interact at the atomic level.

15 Jun 2004

Real-Time Immuno-PCR has the ability to detect HIV infection earlier than all current methods

Researchers at the Institute of Human Virology have developed an ultra-sensitive testing technique that has shown the ability to detect HIV infection earlier than all current methods.

15 Jun 2004

People with extremely early or extremely late sleep times may suffer from Circadian Rhythm Sleep Disorder

You probably know "night owls," those people not ready to fall asleep until the wee hours of the morning. And, you may also know "larks," those early risers who wake before the sun comes up and are ready for bed right after dinner. People with extremely early or extremely late sleep times may suffer from Circadian Rhythm Sleep Disorder (CRSD).

11 Jun 2004

Project aimed at eliminating anthrax as a potential weapon for terrorists

La Trobe University scientists are using their own unique peptide 'library' containing a thousand million molecular sequences in a project aimed at eliminating anthrax as a potential weapon for terrorists.

10 Jun 2004

New statistical techniques for cancer diagnosis

CSIRO statisticians have developed a new way to subtype paediatric Acute Lymphoblastic Leukaemia (ALL), the most common form of cancer in children under 12.

9 Jun 2004

UK company to diagnose disease by breath test

The latest spin-out company from Oxford University, Oxford Medical Diagnostics Ltd, hopes to develop a way of diagnosing disease simply by testing someone's breath.

7 Jun 2004

Australian scientists have developed a tool that acts as a pregnancy test for the detection of anthrax

Once a deadly disease associated with animals, anthrax is now used as a bioterrorist weapon. While infection can be controlled with antibiotics, in a bioterrorism attack people will not know they have been infected until symptoms develop, at which stage drugs are useless.

7 Jun 2004

Australia's CSIRO to exhibit major display at the world's largest biotechnology conference

CSIRO is mounting a major display of technologies this week at BIO 2004, the world's largest biotechnology conference, being held in San Francisco, USA, from 6-9 June.

7 Jun 2004

Drug Tarceva improves survival chance for patients with advanced lung cancer

Roche OSI Pharmaceuticals and Genentech today announced that their investigational drug Tarceva(TM) (erlotinib) achieved a significant 42.5% improvement in median survival compared to placebo in patients with advanced non-small cell lung cancer (NSCLC).

5 Jun 2004

Diagnostics News and Research

Myriad Genetics awarded a $14.2 million contract for AIDS and hepatitis research

Dexrazoxane reduces heart damage caused by childhood leukemia treatment with doxorubicin (Adriamycin)

Emerging infectious diseases will continue to confront society in unpredictable ways as long as humans and microbes co-exist

Gum disease vaccination aim of world-first research

Delphi expands medical footprint

Australian biomedical scientists tackle malaria with on-line malaria information resource

62 percent of frequent antihistamine users did not test positive for allergies

New medical imaging equipment provides early detection of skin cancer

Genetic variation that doubles the risk for rheumatoid arthritis

Biotech organization receives $1 million form Bill & Melinda Gates

New Cincinnati adult diabetes center

New software helps understanding of protein-protein docking

Real-Time Immuno-PCR has the ability to detect HIV infection earlier than all current methods

People with extremely early or extremely late sleep times may suffer from Circadian Rhythm Sleep Disorder

Project aimed at eliminating anthrax as a potential weapon for terrorists

New statistical techniques for cancer diagnosis

UK company to diagnose disease by breath test

Australian scientists have developed a tool that acts as a pregnancy test for the detection of anthrax

Australia's CSIRO to exhibit major display at the world's largest biotechnology conference

Drug Tarceva improves survival chance for patients with advanced lung cancer

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News